Obesity Imprints Lasting Memory on Immune Cells

A 10-year study reveals how obesity leaves a persistent mark on helper T cells (CD4+ lymphocytes) through DNA methylation, potentially increasing disease risk even after weight loss. Published in EMBO Reports, the research led by Claudio Mauro from the University of Birmingham shows these epigenetic tags endure 5-10 years post-weight loss. This immune cell memory disrupts normal functions like waste clearance and immune aging, leaving individuals vulnerable to obesity-related conditions such as type 2 diabetes and certain cancers.

The team analyzed immune cells from diverse human groups to map obesity's immune impact. They collected blood from patients using weight loss injections, those with Alstrom Syndrome (a genetic disorder causing early-onset childhood obesity) matched with healthy pairs, participants in a 10-week exercise program (providing blood and fat tissue), and normal-weight or obese individuals undergoing hip or knee replacement surgery for osteoarthritis. Mouse models on high-fat diets and healthy human blood donations further clarified the cellular mechanisms behind immune dysregulation.

According to Professor Mauro, “The findings suggest that short-term weight loss may not immediately reduce the risk of some disease conditions associated with obesity, including type 2 diabetes and some cancers.

“Instead, ongoing weight management following loss will see the ‘obesity memory’ slowly fade. This may take several years of sustained weight loss maintenance, likely 5-10 years, though this requires further study, to fully reverse the effects of obesity on T cells.

“Additionally, our study suggests potential therapeutic opportunities to expedite this process, such as repurposing drugs like SGLT2 inhibitors, which have shown promise in reducing inflammation and promoting immune-mediated clearance of senescent cells in obesity.” 

The study identifies two key pathways affected by this tagging: autophagy, where cells break down their own waste, and immune senescence, or ageing of the immune system. These changes impair typical immune activities, but the findings point toward targeted treatments to restore function, complementing weight loss therapies to lower risks of metabolic diseases and cancer.

Senior author Belinda Nedjai noted: “Our findings show that obesity is associated with durable epigenetic modifications that influence immune cell behaviour. This suggests that the immune system retains a molecular record of past metabolic exposures, which may have implications for long-term disease risk and recovery.”